Previous studies have shown that single agent cisplatin and 5-FU increase PD-L1 on the surface of lung cancer [27] and OAC cells [28]in vitro respectively, which may drive immune evasion and resistance to chemotherapy. The gene discussed is CD274; the disease is lung carcinoma.